FindTrial
Sign In

We Evaluated Adult Patients with Long-standing Psoriasis for Depression and Anxiety to Evaluate the Mental Effects of Psoriasis and Its effect on the Quality of Life.

Understanding Depression and Anxiety in Adult Patients with Psoriasis: A Prospective Observational Study at a Tertiary Care Teaching Hospital in Southern India

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2021/04/032731
Enrollment
60
Registered
2021-04-12
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: L409- Psoriasis, unspecified

Interventions

None listed

Sponsors

Belagavi Institute of Medical Sciences
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosis of psoriasis for at least 12 months

Exclusion criteria

Exclusion criteria: - Congenital illness - Psychiatric illness - Endocrine illness - Cardiovascular illness - Neurological illness - Rheumatological illness - Malignancies

Design outcomes

Primary

MeasureTime frame
To evaluate the prevalence of anxiety and depression in adult patients with chronic psoriasis and evaluate the correlation between the severity of psoriasis and severity of anxiety and depressionTimepoint: Single visit—

Secondary

MeasureTime frame
Assess the relationship between DLQI and parameters of psoriasis.Timepoint: Single visit;To assess the relationship between clinical variables of psoriasis, drug history for psoriasis, and severity of anxiety and depression.Timepoint: Single visit—

Countries

India

Contacts

Public ContactDr Naveen M

Belagavi Institute of Medical Sciences

gajananpise@gmail.com

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026